Sign in

NCT03232411Completed

Biobank for African American Prostate Cancer Research in Florida

Source: ClinicalTrials.gov · Last updated 4 Dec 2025

Brief summary (registry, in English)

The purposes of this study are: a) to develop a statewide Biobank for prostate cancer among men of African Ancestry in Florida and; b) to examine whether smoking increases the aggressiveness of prostate cancer using several biological approaches. Investigators plan to contact African American prostate cancer patients regarding participation. This project has 3 main components. Eligible patients may choose to participate in any or all parts of the study: Questionnaires; Saliva Samples; Tumor Tissue.

Status (registry)
Completed
Study type
Observational
Enrollment
592 (actual)
First submitted
17 Jul 2017
Start date
22 Mar 2017
Primary completion date
30 Dec 2022
Lead sponsor
H. Lee Moffitt Cancer Center and Research Institute
NCT number
NCT03232411

What you commit to

  • Study type: Observational
  • Participants enrolled: 592
  • From 22 Mar 2017 to the primary completion date, 30 Dec 2022
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Does not meet Inclusion Criteria

Who the study is looking for

  • The initial recruitment of cases will be done with 3 mailings: the first to introduce the study to the participant from Florida Cancer Data System (FCDS) of the Florida Department of Health and ask them to complete the eligibility form and contact information update form; a second mailing to those who are determined to be eligible for the study to obtain the Informed Consent Form and the Baseline survey; and a third mailing to those who completed the survey to obtain a saliva sample and medical release form for tissue.
  • Histologically biopsy confirmed, primary prostate cancer, diagnosed between January 2013 and December 2015
  • African American or Black; Hispanic Black; Afro-Caribbean
  • Are at least 20 years old
  • Are a resident of Florida
  • Additional criteria may apply

Age in the registry: 20 years to - · Sex: Male · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
H Lee Moffitt Cancer Center and Research Institute
Coordinator of this site? Confirm its status
TampaUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.